Dr. Tamara Hannon talks about how many of her pediatric type 2 diabetes patients are overweight (nearly 100%) and how she determines whether they are type 1 or type 2 (mainly through testing for antibodies). She also discusses how all children are currently at risk for obesity and that around …
Read More »Tamara Hannon, MD: Type 2 Diabetes Complications in Children and Teens
Dr. Tamara Hannon talks about the difficult subject of type 2 diabetes complications for adolescents and the challenges they face with the prospect of a longer life with type 2. She also discusses some of the research that has come out that seems to show the disease progressing faster in …
Read More »Tamara Hannon, MD, Q9: How Do Pediatric Type 2 Diabetes Patients Transition to Adult Care Practitioners?
Dr. Tamara Hannon explains how her type 2 patients make the transition to adult-care physicians. Because type 2 is far more common in adults, endocrinologists and physicians who treat adults are actually more used to treating the disease than pediatricians who rarely see type 2 patients.
Read More »Tamara Hannon, MD, Q10: What is the Near-term Future of Type 2 Diabetes in Kids?
Dr. Tamara Hannon addresses Steve’s questions on the future of type 2 diabetes in children, noting that unless we can begin to make changes as a society, the rates will just keep increasing as the obesity rates just keep going up.
Read More »ADA: New HbA1c Target of 7.5% for Type 1 Children and Older Adults
Recent scientific evidence and better tools to monitor for hypoglycemia helped establish the new position statement…. Anne Peters, MD, FACP, professor at the Keck School of Medicine, University of Southern California, said during a press conference at the American Diabetes Association’s 74th Scientific Sessions, “Our goal here is to present …
Read More »ADA: Depression Predicts Type 1 Diabetes Death
Depression has been linked with worse survival in a 20-year observational study of patients with type 1 diabetes….
Read More »ADA: Diabetes Prevention Program 15 Years Later
Findings suggest clinicians can prevent or delay the onset of type 2 diabetes "over a very long period of time"….
Read More »ADA: Prediabetes Intervention Cuts Cardiovascular Risk
Treatment of prediabetes and prevention of type 2 diabetes reduces cardiovascular risk….
Read More »Joslin’s Diabetes Deskbook, Updated 2nd Ed., Excerpt #51: Pharmacotherapy of Type 2 Diabetes, Part 10
Richard S. Beaser, MD Medications that Increase Insulin Secretion: SULFONYLUREAS CLASS SUMMARY: Action: Insulin secretagogues. Initial effects are to increase insulin secretory capacity. With establishment of long-term glucose control, this increase may not persist and other extrapancreatic effects, either direct or indirect, may also occur. Required for efficacy: Some remaining …
Read More »Adding Insulin as the Second Treatment for Type 2’s May Increase Risk of Death
Among diabetes patients receiving metformin, the addition of insulin compared with a sulfonylurea was associated with an increased risk of nonfatal cardiovascular outcomes and all-cause death….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.